On Monday, Costco Wholesale Corporation (NASDAQ:COST)’s shares inclined 0.25% to $145.04.
Costco Wholesale Corporation ( COST) stated net sales of $11.01 billion for the month of June, the five weeks ended July 5, 2015, an enhance of one percent from $10.88 billion during the similar period last year. Both years’ five-week periods comprised of 34 selling days in the U.S. and Canada, reflecting the observance of Independence and Canada Days. For the forty-four weeks ended July 5, 2015, the Company stated net sales of $96.32 billion, an enhance of four percent from $92.88 billion during the similar period last year.
Costco Wholesale Corporation, together with its auxiliaries, operates membership warehouses. The company offers branded and private-label products in a range of merchandise categories. It provides dry and institutionally packaged foods; snack foods, candy, tobacco, alcoholic and nonalcoholic beverages, and cleaning and institutional supplies; appliances, electronics, health and beauty aids, hardware, garden and patio, and office supplies; meat, bakery, deli, and produce; and apparel, small appliances, and home furnishings.
Cardinal Health Inc (NYSE:CAH)’s shares dropped -0.21% to $86.58.
Cardinal Health Inc (CAH) declared the completion of the acquisition of The Harvard Drug Group (THDG). A distributor of generic pharmaceuticals, over-the-counter medications and related products to retail, institutional and alternate care customers, THDG was owned by Court Square Capital Partners. The $1.115 billion acquisition was an all-cash transaction using existing cash and new debt.
Headquartered in Livonia, Mich., The Harvard Drug Group had revenues of about $450 million in 2014. There are 450 employees and two distribution facilities comprised of in the transaction.
In addition to enhancing the company’s generic pharmaceutical distribution business, the acquisition expands Cardinal Health’s existing telesales programs and capabilities; broadens the company’s portfolio of over-the counter pharmaceutical products; and brings specialized packaging offerings to meet the needs of hospital systems and other institutions.
Cardinal Health, Inc., a healthcare services company, provides pharmaceutical and medical products and services in the United States and internationally. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare, specialty pharmaceutical, and consumer products to retailers, including chain and independent drug stores and pharmacy departments of supermarkets and mass merchandisers; hospitals; and other healthcare providers.
At the end of Monday’s trade, FormFactor, Inc. (NASDAQ:FORM)‘s shares dipped -6.54% to $6.86.
FormFactor, Inc. (NASDAQ: FORM) will report financial results for its 2015 fiscal second quarter on Wednesday, July 29, 2015, at 1:30 p.m. Pacific Daylight Time. The public is invited to listen to a live webcast of FormFactor’s conference call on the Investors section of the company’s web site at www.formfactor.com. A telephone replay of the conference call will be accessible about two hours after the conclusion of the call.
FormFactor, Inc. designs, develops, manufactures, sells, and supports semiconductor probe card products and solutions worldwide. The company’s probe cards are used to perform wafer test, which is the testing of the semiconductor die or chips on the semiconductor wafer. Its probe cards are used to test DRAM chips, counting LPDDR2, LPDDR3, LPDDR4, DDR, DDR2, DDR3, DDR4, SDRAM, PSRAM, and graphic DRAM; NOR, PCM, and NAND flash memory chips; and system-on-chip (SoC) devices, such as serial data devices, chipsets, microprocessors, microcontrollers, graphic processors, mobile RF, and analog and mixed-signal devices.
Catamaran Corp (USA) (NASDAQ:CTRX), ended its Monday’s trading session with XXX% gain loss, and closed at $61.44.
Catamaran Corp. (CTRX), a leading provider of pharmacy benefit administration (PBM) services and technology, and Health New England, Inc. (HNE), a health maintenance organization in Massachusetts, recently declared one-year results from Catamaran’s Hospital Transition Program, which dramatically reduced HNE’s hospital readmission rates and raised medication adherence.
Prior to implementing Catamaran’s Hospital Transition Program, HNE evaluated its commercial members that were re-admitted to a hospital within 30 days of discharge and found that 30 percent of those patients were taking more than six chronic medications simultaneously. This finding made implementing a program that promoted medication adherence critically important to assisting these members stay out of the hospital.
Catamaran Corporation provides pharmacy benefit administration (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefits administration industry in North America. The company operates in two segments, PBM and HCIT. The PBM services comprise electronic point-of-sale pharmacy claims administration, retail pharmacy network administration, mail and specialty pharmacy claims administration, Medicare Part D services, benefit design consultation, preferred drug administration programs, drug review and analysis, consulting services, data access, and reporting and information analysis. It owns and operates a network of mail and specialty pharmacies.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
